BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4120334)

  • 1. Rational chemotherapy: inhibition of polymerase activity of cancer cells.
    Knock FE; Galt RM; Oester YT; Sylvester R
    JAMA; 1973 Apr; 224(1):129. PubMed ID: 4120334
    [No Abstract]   [Full Text] [Related]  

  • 2. Detergent effects on a reverse transcriptase activity and on inhibition by rifamycin derivatives.
    Thompson FM; Libertini LJ; Joss UR; Calvin M
    Science; 1972 Nov; 178(4060):505-7. PubMed ID: 4116919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxime derivatives of erythromycin: inhibitors of Rous sarcoma virus reverse transcriptase activity and focus formation.
    Hung PP
    J Gen Virol; 1975 Jan; 26(1):135-9. PubMed ID: 47382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifamycins as inhibitors of retroviral reverse transcriptase from M-MuLV, RAV-2, and HIV-1.
    Bartolucci C; Cellai L; Di Filippo P; Segre A; Brufani M; Filocamo L; Bianco AD; Guiso M; Brizzi V; Benedetto A
    Farmaco; 1992 Nov; 47(11):1367-83. PubMed ID: 1283514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In-vitro effect of DNA polymerases].
    Piller G; Deutsch E; Moser K; Rainer H
    Verh Dtsch Ges Inn Med; 1974; 80():1652-4. PubMed ID: 4141824
    [No Abstract]   [Full Text] [Related]  

  • 6. In-vitro inhibition of RNA-instructed DNA polymerase.
    Rainer H; Lutz D; Stacher A; Deutsch E; Moser K
    Arzneimittelforschung; 1975 May; 25(5):735-7. PubMed ID: 52362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships in open ansa-chain rifamycin S derivatives as inhibitors of HIV-1 reverse transcriptase.
    Bartolucci C; Cellai L; Marzano M; Segre A; Brufani M; Filocamo L; Bianco AD; Guiso M; Brizzi V; Benedetto A
    Farmaco; 1995 Sep; 50(9):587-93. PubMed ID: 7495468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenesis.
    Calvin M
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(9):683-97. PubMed ID: 4139733
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity of transformed and nontransformed cells to amphotericin B and several rifamycin derivatives.
    Medoff G; Schlessinger D; Kobayashi GS
    Cancer Res; 1974 Apr; 34(4):823-6. PubMed ID: 4360842
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of two rifamycin derivatives on the Rous sarcoma virus transformation system.
    Barlati S; Vigier P
    J Gen Virol; 1972 Nov; 17(2):221-5. PubMed ID: 4344314
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifamycins--obstacles and opportunities.
    Aristoff PA; Garcia GA; Kirchhoff PD; Showalter HD
    Tuberculosis (Edinb); 2010 Mar; 90(2):94-118. PubMed ID: 20236863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis.
    Burman WJ; Gallicano K; Peloquin C
    Clin Infect Dis; 1999 Mar; 28(3):419-29; quiz 430. PubMed ID: 10194057
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rifamycin].
    Acocella G
    G Ital Chemioter; 1983; 30(1):1-24. PubMed ID: 6363192
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro and in vivo chemotherapeutic activity of rifabutin (LM 427) on Mycobacterium avium-intracellulare complex.
    Sakurai N; Kuze F
    Bull Chest Dis Res Inst Kyoto Univ; 1987 Mar; 20(1-2):50-60. PubMed ID: 2836007
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifalazil.
    Tuberculosis (Edinb); 2008 Mar; 88(2):148-50. PubMed ID: 18486057
    [No Abstract]   [Full Text] [Related]  

  • 17. Harnessing the full sterilising activity of rifamycins.
    Leung CC; Yew WW; Grosset J
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):429-30. PubMed ID: 21396197
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential mechanisms of action of antiviral agents.
    Prusoff WH; Goz B
    Fed Proc; 1973 Jun; 32(6):1679-87. PubMed ID: 4122954
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR).
    Hu XC; Chow LW
    Eur J Surg Oncol; 2000 Sep; 26(6):530-5. PubMed ID: 11034801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editoral: ICRF 159.
    Lancet; 1974 Mar; 1(7853):344-5. PubMed ID: 4131178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.